drugset / Trial / NCT07537413
Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia
RandomizedParallel-groupOpen-labelTreatment
Summary
Aim: Demonstrate the equivalent efficacy and superior safety of Ceftriaxone 1 gram daily compared with Ceftriaxone 2 grams daily among hospitalized patients with community-acquired pneumonia who are not admitted to the intensive care unit.\<p\> Hypothesis: Among hospitalized patients outside of the intensive care unit with community-acquired pneumonia who are prescribed Ceftriaxone, a dosage of 1 gram daily will be associated with an equivalent rate of clinical cure and fewer adverse events than a dosage of 2 grams daily.
Timeline
- Start
- 2026-09-01
- Primary completion
- 2027-08-31
- Completion
- 2028-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ceftriaxone | Other / unclassified | 1 g | Intravenous |
| Comparator | Ceftriaxone | Other / unclassified | 2 g | Intravenous |